Cited by 188Cancer Genomics and DiagnosticsChromatin Remodeling and CancerEvolution and Genetic Dynamics

Evolution of the cancer genome

Open access
Podlaha, Ondrej, Riester, Markus, De, Subhajyoti, Michor, Franziska·2012·Trends in Genetics

Abstract

Human tumors result from an evolutionary process operating on somatic cells within tissues, whereby natural selection operates on the phenotypic variability generated by the accumulation of genetic, genomic and epigenetic alterations. This somatic evolution leads to adaptations such as increased proliferative, angiogenic, and invasive phenotypes. In this review we outline how cancer genomes are beginning to be investigated from an evolutionary perspective. We describe recent progress in the cataloging of somatic genetic and genomic alterations, and investigate the contributions of germline as well as epigenetic factors to cancer genome evolution. Finally, we outline the challenges facing researchers who investigate the processes driving the evolution of the cancer genome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tig.2012.01.003

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several recent studies have shown a similar spectrum of genetic alterations to those observed here during the somatic evolution of cancers in patients undergoing chemotherapy or treated with specific inhibitors.

    “Indeed, several recent studies have shown a similar spectrum of genetic alterations to those observed here during the somatic evolution of cancers in patients undergoing chemotherapy (Podlaha et al., 2012; Landau et al., 2013) or treated with specific inhibitors (Ding et al., 2012) to those observed here.”

    From The evolution of drug resistance in clinical isolates of Candida albicans. (2015) · cites this paper as Podlaha et al., 2012

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 103 · Cited by 188

Authors
Podlaha, O., Riester, M., De, S., & Michor, F.
Affiliations
Harvard University (US)
Venue
Trends in Genetics
Publisher
Elsevier BV
Published
2012-04
Volume
28
Issue
4
Pages
155-163
ISSN
0168-9525 (ISSN-L)
OpenAlex
W2067507447
Cited by
188
References
103
Citations by year
2026: 3 · 2025: 9 · 2024: 11 · 2023: 14 · 2022: 12 · 2021: 17 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 12 · 2016: 15 · 2015: 19 · 2014: 22 · 2013: 16 · 2012: 5
FWCI
1.43
Type
journal article
Language
en
Open access
Locations
  • Trends in Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (U54CA143798)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords
cancer genome evolution, somatic evolution, tumor evolution, somatic mutations, somatic copy number alterations, epigenetic modifications, germline predisposition, tumor heterogeneity, tumor microenvironment, tumor invasion, angiogenesis, tumor cell proliferation
MeSH terms
Animals, Humans, Neoplasms, Genome, Disease Progression, Evolution, Molecular, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review